Holen Sie sich die Stockscreener-App
11.02
0.99%
-0.11
Handel nachbörslich:
11.02
Oculis Holding Ag Aktie (OCS) Neueste Nachrichten
Oculis Holding AG (OCS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Oculis Holding AG (OCS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Oculis Holding AG (OCS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Oculis Holding AG (OCS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Oculis Holding AG (OCS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Oculis Holding AG (OCS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
OCS|Oculis Holding AG|Price:11.130|Chg%:-0.310 - TradingKey
Oculis Holding AG Revenue Breakdown – NASDAQ:OCS - TradingView
OCS|Oculis Holding AG|Price:11.040|Chg%:-0.090 - TradingKey
Oculis Holding AG (OCS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Technical Reactions to OCS Trends in Macro Strategies - Stock Traders Daily
Guggenheim initiates coverage of Oculis Holding (OCS) with buy recommendation - MSN
Oculis Holding AG (OCS) Investigation: Bronstein, Gewirtz & Gross - The National Law Review
Number of shareholders of Oculis Holding AG – NASDAQ:OCSAW - TradingView
Price to sales forward of Oculis Holding AG – NASDAQ:OCSAW - TradingView
Price to book forward of Oculis Holding AG – NASDAQ:OCSAW - TradingView
Oculis Holding AG (OCS) Slightly Gains, Nearing Key Resistance LevelVolume Nodes - dars.gov.et
Bronstein, Gewirtz & Grossman, LLC Is Investigating Oculis Holding AG (OCS) And Encourages Investors to Connect - The National Law Review
Enterprise value to revenue forward of Oculis Holding AG – NASDAQ:OCSAW - TradingView
Enterprise value to EBITDA forward of Oculis Holding AG – NASDAQ:OCSAW - TradingView
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - marketscreener.com
Oculis director's RSUs vest and settle, signali... - Pluang
Price to book forward of Oculis Holding AG – SWB:CR5 - TradingView
Price to earnings forward of Oculis Holding AG – NASDAQ:OCS - TradingView
Price to sales forward of Oculis Holding AG – NASDAQ:OCS - TradingView
Enterprise value to revenue forward of Oculis Holding AG – SWB:CR5 - TradingView
Oculis Holding AG Warrants 2023-06.03.28 on OCULIS HOLDING Financial Disclosures & SEC Filings - TradingView
Oculis stock gains after FDA trial design agreement - Investing.com
Oculis stock gains after FDA trial design agreement By Investing.com - Investing.com Nigeria
Oculis to present updates on late-stage eye dis... - Pluang
Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference - The Manila Times
Oculis to Participate in Piper Sandler Virtual Ophthalmology Conference Fireside Chat - Quiver Quantitative
Trading the Move, Not the Narrative: (OCS) Edition - Stock Traders Daily
Oculis Updates Investor Presentation, Emphasizing Late-Stage Neuro-Ophthalmic Pipeline and Cash Runway - TipRanks
Oculis Holding AG Actuals & Estimates (NASDAQ:OCS) - TradingView
Oculis Holding AG Warrants (OCSAW) See Upward Momentum Amid Modest GainsSign of Strength - dars.gov.et
Oculis (NASDAQ: OCS) details late-stage eye drugs and cash runway into 2029 - Stock Titan
OCS Forecast — Price Target — Prediction for 2027 - TradingView
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AGOCS - PR Newswire
Oculis Holding AG (OCS) Slips 1.37% as Shares Test Key Support LevelDip Buy Trade - dars.gov.et
OCSOculis Holding AG Revenue Breakdown - Finviz
Pomerantz investigates Oculis over failed drug trials and stock drop - Pluang
Oculis Holding AG (OCS) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Focuses on Pipeline ProgressCash Flow Report - dars.gov.et
Oculis Holding AG (OCS) Edges Lower Amidst Sector Headwinds; Support Levels in FocusRegression Channel - dars.gov.et
(OCS) Volatility Zones as Tactical Triggers - Stock Traders Daily
Oculis Holding AG (OCS) Institutional Confidence - TradingKey
OCS News | OCULIS HOLDING AG (NASDAQ:OCS) - ChartMill
Oculis Holding AG (OCS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Oculis Holding AG (OCSAW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Oculis Holding AG (OCSAW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Oculis Holding AG (OCSAW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Oculis Holding AG (OCSAW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Oculis Holding AG (OCSAW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Oculis Holding AG (OCSAW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Oculis Holding AG (OCSAW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Oculis Holding AG (OCSAW) Institutional Confidence - TradingKey
OCS Investors Have Opportunity to Join Oculis Holding AG Fraud Investigation with the Schall Law Firm - GlobeNewswire
Oculis : Minutes of the 2026 Annual General Meeting of Shareholders - marketscreener.com
Investors sue Oculis Holding AG over failed dru... - Pluang
Bronstein, Gewirtz & Grossman, LLC Is Investigating Oculis Holding AG (OCS) And Encourages Shareholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Oculis Holdin - The National Law Review
Law firm investigates Oculis after failed drug trials and stock drop. - Pluang
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):